Fusion Pharmaceuticals Inc. Earnings Per Share (Diluted)
Fusion Pharmaceuticals Inc. reported Earnings Per Share (Diluted) of -$0.40 per share for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2024-05-07
- Fusion Pharmaceuticals Inc. earnings per share, diluted for the quarter ending 2024-03-31 was -$0.40.
- Fusion Pharmaceuticals Inc. earnings per share, diluted for the quarter ending 2023-12-31 was -$0.39.
- Fusion Pharmaceuticals Inc. earnings per share, diluted for the quarter ending 2023-09-30 was -$0.25.
- Fusion Pharmaceuticals Inc. earnings per share, diluted for the quarter ending 2023-06-30 was -$0.38.
- Fusion Pharmaceuticals Inc. earnings per share, diluted for fiscal 2023 was -$1.45.
- Fusion Pharmaceuticals Inc. earnings per share, diluted for fiscal 2022 was -$2.00.
- Fusion Pharmaceuticals Inc. earnings per share, diluted for fiscal 2021 was -$1.90.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$0.40 10-Q · filed 2024-05-07 | -$0.79 derived: net income ÷ weighted average shares · filed 2024-05-07 | -$1.05 derived: net income ÷ weighted average shares · filed 2024-05-07 | -$1.43 derived: net income ÷ weighted average shares · filed 2024-05-07 |
| 2023-12-31 | -$0.39 derived: net income ÷ weighted average shares · filed 2024-03-20 | -$0.64 derived: net income ÷ weighted average shares · filed 2024-03-20 | -$1.02 derived: net income ÷ weighted average shares · filed 2024-03-20 | -$1.45 10-K · filed 2024-03-20 |
| 2023-09-30 | -$0.25 10-Q · filed 2023-11-07 | -$0.63 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.06 10-Q · filed 2023-11-07 | -$1.56 derived: net income ÷ weighted average shares · filed 2024-05-07 |
| 2023-06-30 | -$0.38 10-Q · filed 2023-08-08 | -$0.82 10-Q · filed 2023-08-08 | -$1.35 derived: net income ÷ weighted average shares · filed 2024-05-07 | -$1.88 derived: net income ÷ weighted average shares · filed 2024-05-07 |
| 2023-03-31 | -$0.45 10-Q · filed 2024-05-07 | -$0.99 derived: net income ÷ weighted average shares · filed 2024-05-07 | -$1.54 derived: net income ÷ weighted average shares · filed 2024-05-07 | -$1.98 derived: net income ÷ weighted average shares · filed 2024-05-07 |
| 2022-12-31 | -$0.55 derived: net income ÷ weighted average shares · filed 2024-03-20 | -$1.10 derived: net income ÷ weighted average shares · filed 2024-03-20 | -$1.54 derived: net income ÷ weighted average shares · filed 2024-03-20 | -$2.00 10-K · filed 2024-03-20 |
| 2022-09-30 | -$0.55 10-Q · filed 2023-11-07 | -$0.99 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.45 10-Q · filed 2023-11-07 | -$1.85 derived: net income ÷ weighted average shares · filed 2023-11-07 |
| 2022-06-30 | -$0.44 10-Q · filed 2023-08-08 | -$0.90 10-Q · filed 2023-08-08 | -$1.30 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.75 derived: net income ÷ weighted average shares · filed 2023-11-07 |
| 2022-03-31 | -$0.46 10-Q · filed 2023-05-11 | -$0.86 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.31 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.94 derived: net income ÷ weighted average shares · filed 2023-11-07 |
| 2021-12-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$0.85 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$1.48 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$1.90 10-K · filed 2023-03-16 |
| 2021-09-30 | -$0.45 10-Q · filed 2022-11-08 | -$1.08 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$1.50 10-Q · filed 2022-11-08 | |
| 2021-06-30 | -$0.63 10-Q · filed 2022-08-09 | -$1.05 10-Q · filed 2022-08-09 |